mRNA-based drugs are setting themselves apart from conventional protein therapeutics in cell and gene therapy, vaccine, and gene editing arenas. As scientists develop and manufacture novel mRNA therapeutics, they must find technologies that help analyze their drug products on a large scale. Direct mRNA sequence mapping with mass spectrometry is a novel workflow for rapidly fragmenting and assessing mRNA.
Download this ebook from Thermo Fisher Scientific to learn about mRNA therapeutics and the direct mRNA sequencing workflow.
